Japan's Nasukai and Shanghai's Daibi Medical Aesthetics Form Strategic Alliance to Boost Services in China

Strategic Partnership Forged Between Japanese and Chinese Medical Aesthetics Leaders

Medical Corporation Nasukai, a Japan-based entity supported by SBC Medical Group Holdings Incorporated and operator of the renowned Shonan Beauty Clinic, has officially entered into a strategic business alliance with Daibi Medical Aesthetics, a prominent medical aesthetic clinic located in Shanghai, China. The alliance, announced on February 1, 2026, seeks to elevate the standard of medical aesthetic services in China and capitalize on the burgeoning cross-border medical tourism market.

Enhancing Service Quality and Brand Recognition

The core objective of this strategic collaboration is to significantly enhance the quality of services offered at Daibi Medical Aesthetics. This will be achieved through the sharing of Nasukai's extensive clinical expertise, operational know-how, and customer-centered practices, which have been honed over years of experience in aesthetic medicine. Furthermore, the partnership aims to strengthen the recognition of the Shonan Beauty Clinic brand in China, emphasizing its commitment to safety standards and advanced medical technologies.

Under the terms of the alliance, physicians affiliated with Nasukai will actively work within Daibi Medical Aesthetics' clinical framework. This direct involvement will facilitate the transfer of knowledge and expertise concerning medical safety protocols, clinic operations, and effective consultation practices. Both parties are also set to explore opportunities for mutual understanding and professional exchange in the field of aesthetic medicine between Japan and China, with specific initiatives to be considered in phases.

Tapping into China's Dynamic Medical Aesthetics Market

This alliance comes at a time of significant growth and opportunity within the Chinese medical aesthetics sector. China's market is characterized by rapid expansion, driven by an increasing demand for cosmetic procedures and a surge in younger, tech-savvy consumers. The market saw a 20% expansion in 2023, with revenues reaching approximately 200 billion yuan ($27.6 billion). Key trends include a rising preference for non-invasive procedures, technological innovations, and increased spending power among high-end consumers.

Despite its rapid growth, China's medical aesthetics market penetration rate, which stood at 4.5% in 2022, still lags behind more developed markets like Japan, the United States, and South Korea. This indicates substantial room for future development. The partnership also aims to deepen SBC Medical's understanding of China's medical environment and customer needs.

Leveraging the Rise of Medical Tourism

The collaboration is strategically positioned to benefit from the growing global interest in medical tourism. The global medical tourism market is projected to grow at a compound annual growth rate (CAGR) of 23.0% from 2024 to 2032, potentially reaching approximately $62.18 billion by 2032. Chinese consumers, in particular, are increasingly traveling to Japan for cosmetic procedures, drawn by Japan's reputation for advanced techniques, qualified medical staff, and high-end customer experiences. This alliance is expected to support increased inbound customer visits to Shonan Beauty Clinic in Japan and explore long-term revenue opportunities associated with this cross-border medical demand.

Daibi Medical Aesthetics, established in 2021 and operating a 2,200 square meter clinic in Shanghai's North Bund area since 2022, provides community-based medical aesthetic services, making it a key local partner for this international expansion.